Visual and Anatomical Outcome Of Ozurdex Implant In Non-Infectious Intermediate Or Posterior Uveitis In Treatment Naive Patients
Aim:- To determine the visual and anatomical outcome of Ozurdex implant in non-infectious intermediate or posterior uveitis in treatment naïve patients. Design:- Retrospective study. Materials and Methods:- 25 eyes receiving Ozurdex implant (0.7mg dexamethasone) for treatment of naïve non-infectious...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2018-04-01
|
| Series: | Delhi Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.7869/djo.349 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Aim:-
To determine the visual and anatomical outcome of Ozurdex implant in non-infectious intermediate or posterior uveitis in treatment naïve patients.
Design:-
Retrospective study.
Materials and Methods:-
25 eyes receiving Ozurdex implant (0.7mg dexamethasone) for treatment of naïve non-infectious intermediate or posterior uveitis with cystoid macular edema (CME) having a minimum 6 month follow up. Best corrected visual acuity (BCVA) and central foveal thickness (CFT) was measured at baseline, 1, 3 & 6 months.
Results:-
Mean baseline logMAR BCVA improved significantly from 0.477 to 0.181 (p<0.05) at 3 months and to 0.193 (p<0.05) at 6 months. The mean CFT reduced from its baseline value of 481.3µto 250.41µ (p<0.05) at 3 months and to 274.8µ(p<0.05) at 6 months.
Conclusion:-
Significant improvement in BCVA and CFT from baseline to 3 and 6 months has proven Ozurdex implant to be a promising treatment option in cases of treatment naïve non-infectious posterior uveitis. |
|---|---|
| ISSN: | 0972-0200 2454-2784 |